ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,140 | +48001.4% | 28,034 | -7.8% | 0.02% | -48.7% |
| Q2 2023 | $651 | -47.4% | 30,414 | -0.5% | 0.04% | -48.7% |
| Q1 2023 | $1,237 | -15.1% | 30,579 | -2.4% | 0.08% | -15.6% |
| Q4 2022 | $1,457 | -100.0% | 31,329 | -55.5% | 0.09% | -62.5% |
| Q3 2022 | $3,648,000 | -0.3% | 70,324 | -9.2% | 0.24% | +5.7% |
| Q2 2022 | $3,660,000 | -50.8% | 77,420 | -25.9% | 0.23% | -42.5% |
| Q1 2022 | $7,438,000 | -2.5% | 104,494 | +2.4% | 0.40% | +5.3% |
| Q4 2021 | $7,632,000 | +11.7% | 102,064 | -15.1% | 0.38% | +4.5% |
| Q3 2021 | $6,831,000 | +24.8% | 120,240 | -3.3% | 0.36% | +22.9% |
| Q2 2021 | $5,474,000 | -2.6% | 124,380 | +9.2% | 0.29% | -13.6% |
| Q1 2021 | $5,620,000 | – | 113,940 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |